Researchers from Osaka University found that gargling with an antiseptic mouthwash can reduce periodontitis-related bacteria in patients with type 2 diabetes. This simple method may improve the lives of people with periodontitis-linked diseases such as diabetes, dementia, and cardiovascular disease.
A study published in the Journal of the American College of Surgeons found that gastric bypass surgery results in high rates of Type-2 diabetes remission five years after the operation, even after patients regain a significant amount of weight. In contrast, patients who underwent sleeve gastrectomy and regained their weight were five t...
A new study finds that Type 2 diabetes causes intervertebral discs to become stiffer and change shape earlier than normal. This leads to a compromised ability to withstand pressure, highlighting the need for preventative and therapeutic strategies.
A new American Heart Association scientific statement emphasizes the need for increased awareness of heart disease as a major health risk for women, particularly those with pregnancy complications. Early detection and treatment of risk factors may help prevent future heart attack, heart failure, and stroke.
Research found that boosting weekly total physical activity by just over an hour is associated with a 33% lower risk of progression to chronic kidney disease. The study also showed that longer bouts of moderate-intensity exercise, even those below 10 minutes, contribute to better outcomes.
A new study published in the American Heart Association journal Hypertension found that tirzepatide significantly lowered systolic blood pressure levels in nearly 500 adults with obesity. The results suggest treating obesity with this weight loss medication may be an effective strategy for preventing or treating high blood pressure.
Researchers found that people with Type 2 diabetes have higher levels of AGEs, leading to more viscoelastic liver tissue, which increases the risk of liver cancer. The study suggests new screening guidelines for this population, potentially improving early detection and treatment.
A recent study published in PNAS suggests that impaired macrophage function plays a key role in the development of type 2 diabetes in obese individuals. The research found that collagen breakdown is handled by macrophages, which become deactivated in obesity and insulin resistance, leading to the accumulation of collagen fragments.
Researchers at Karolinska Institutet developed a method to study liver function and disease using the cornea of mice eyes. They transplanted liver cells into the eyes, creating a non-invasive platform to monitor liver health over time.
Researchers found that SGLT2 inhibitors reduced kidney stone rates by 30% compared to GLP1 agonists and 25% compared to DPP4 inhibitors. The study included data from 716,406 adults with type 2 diabetes who took these medications.
A new study led by University of Bristol researchers found that weight loss in people with type 2 diabetes can alter levels of cancer-related chemicals circulating in the blood. Nine cancer-related proteins were changed by the weight loss intervention, suggesting a potential reduction in cancer risk.
A new review suggests that female reproductive characteristics, such as early menstruation and polycystic ovary syndrome, may contribute to later metabolic dysfunction. The study highlights the importance of screening for reproductive risk factors to aid in prevention or treatment of chronic metabolic diseases.
A international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The standout biomarker was N-terminal pro b-type natriuretic peptide (NT-proBNP), which is currently used to monitor heart failure status in patients.
A recent study by University of Missouri researcher Mansoo Yu found that online weight loss interventions with counseling and social support are effective for middle-aged adults with obesity. The study identified two key features: professional health coaching and access to social support from other users, which led to significant long-...
A nationwide study from Karolinska Institutet found that GLP1 agonists like Ozempic reduce the risk of cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease. Those who continued taking the medication for ten years were half as likely to develop severe liver disease.
A global study review found negative indirect impacts of the pandemic on people with diabetes, including a rise in non-COVID-19-related deaths, diabetic ketoacidosis among children and adolescents, and sight loss. Pediatric ICU admissions were also significantly increased.
A new study found that only 6% of people with type 2 diabetes achieved diabetes remission solely through weight loss by about eight years after diagnosis. People who initially lost a significant amount of weight in the first year were more likely to achieve sustained remission.
Participants with diabetes remission had a 33% lower rate of CKD and a 40% lower rate of CVD compared to those without remission. The magnitude of risk reduction was greatest for participants with longer-term remission.
Researchers found that participants who achieved diabetes remission through weight loss had a 40% lower rate of cardiovascular disease and 33% lower rate of chronic kidney disease. The study, led by Professor Edward Gregg, monitored over 5,000 patients for 12 years.
A new study found that young adults who reported higher stress as adolescents were more likely to have high blood pressure, obesity, and other cardiometabolic risk factors. This highlights the importance of stress management from an early age to prevent these health issues.
A new study published in Nature Communications found that AI-driven eye exams can close care gaps among racial and ethnic minority youth with diabetes, populations with historically higher rates of diabetic retinopathy. The technology uses cameras to take pictures of the back of the eye without dilation and provides immediate results.
A large-scale ancient human gene bank analysis revealed that genetic variants increasing MS risk were introduced by sheep and cattle herders 5,000 years ago. This finding explains the North-South Gradient of MS prevalence in Europe.
A Cornell University study using lab mice with human genes found that male mice exposed to arsenic developed insulin resistance and Type 2 diabetes, while female mice did not. The researchers identified a biomarker called miR-34a associated with insulin resistance in Type 2 diabetes.
A study by Virginia Tech researchers found that medications used to treat Type 2 diabetes, such as Ozempic and Mounjaro, can decrease cravings for alcohol and lead to reduced consumption in individuals with obesity. The findings add to a growing literature on the potential of GLP-1 agonists to curb dangerous drinking habits.
A recent study found that liraglutide, a GLP-1R agonist, rapidly improves insulin sensitivity in individuals with obesity and pre-diabetes. Insulin sensitivity is crucial for controlling blood glucose levels, and improved sensitivity reduces the risk of developing Type 2 diabetes or improving its treatment.
A new study suggests that US adults consume almost a quarter of their daily calories in snacks, often more than they do at breakfast, yet these snacks offer little nutritional value. Researchers analyzed data from over 20,000 people and found that snacks accounted for between 19.5% to 22.4% of total energy intake.
A Leicester study found that weight cycling is associated with worsening body composition and increased risk of physical health issues. Participants who lost and regained weight experienced a significant loss of muscle mass, while gaining all their lost fat.
A new study by Lund University researchers confirms that epigenetic changes can contribute to the development of type 2 diabetes. The study identified 5584 sites with differing epigenetic changes in individuals with and without the disease, as well as a key gene RHOT1 involved in insulin secretion.
A new poll found that 83% of older adults believe health insurers should cover medications to help people with obesity manage their weight. Nearly as many, 76%, also believe Medicare should cover these drugs, which are currently not covered under law.
A Northwestern University study found that nearly two-thirds of patients discontinue or change their medication within a year, highlighting the need for better understanding of barriers to treatment adherence. The high discontinuation rate for GLP-1 RAs may be due to gastrointestinal side effects.
Using metformin plus insulin to treat preexisting type 2 or gestational diabetes diagnosed early in pregnancy did not show a reduction in composite neonatal adverse outcomes. The study suggests that the effect of reducing large-for-gestational-age infant risk after adding metformin to insulin warrants further investigation.
Research shows that Australian children are at risk of excessive weight gain and declining fitness during school holidays. The two-year study found that body fat increased at a faster pace and aerobic fitness declined faster than in-school periods. Promoting physical activities during holidays could help address unhealthy weight gain.
A new study found no increased risk of major congenital malformations in infants exposed to second-line non-insulin antidiabetic medications during pregnancy compared to those treated with insulin. The study examined over 3.5 million pregnancies and provided reassurance on the safety of these medications for fetuses.
A phase 3 trial found that tirzepatide promotes additional weight loss and preserves metabolic health when continued, but discontinuation leads to significant weight regain. Researchers suggest chronic treatment may be necessary for sustained weight loss and improved cardiometabolic risk factors.
A plant-based diet has been shown to reduce the risk of type 2 diabetes by 24%, with benefits attributed to improved metabolism and liver function. Additionally, healthy eating patterns were found to improve organ function, particularly in individuals with genetic predispositions or other risk factors.
A national food choice experiment found that labeling a meat-free and dairy-free food basket as 'vegan' or 'plant-based' leads to lower appeal, whereas labels like 'healthy' or 'sustainable' result in higher preference. This study suggests using these alternative labels can encourage healthier and more environmentally sustainable eatin...
Researchers found that GLP-1 RAs significantly reduced the incidence of colorectal cancer in patients with diabetes, compared to those treated with other anti-diabetic drugs. The study's findings support the need for clinical trials to determine whether these medications could prevent one of the deadliest types of cancers.
A comprehensive study has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. The research provides a template for identifying additional early disease-driving events for Type 2 diabetes.
The international consensus report on precision diabetes medicine highlights significant advancements in prevention, diagnosis, treatment, and prognosis. The report also sheds light on knowledge gaps and provides a framework for future research.
The UTHealth Houston School of Public Health offers a 12-month lifestyle program combining evidence-based nutrition education with culinary learning to support behavior change. Participants will attend in-person and virtual classes, including hands-on cooking lessons, physical activity guidance, and mindfulness education.
According to a new study published in Annals of Internal Medicine, most adults who qualify for statin use for primary prevention are not receiving them. The study found that despite increased overall statin use over time, only 35% of eligible adults were taking statins between 2013 and 2018. The researchers suggest that innovative effo...
Elevated blood glycerol levels are linked to increased TB disease severity in experimental models with Type 2 diabetes. The study identifies glycerol kinase as a crucial enzyme driving TB disease severity.
A research team led by USC's Abigail Horn used smartphone mobility data to find a strong correlation between location visits and diet-related diseases. The study reveals that physical food environments play a crucial role in shaping people's eating decisions, with environments like fast-food joints contributing to unhealthy choices.
A pooled data analysis of 10 studies found that walking speeds above 4 km/hour are associated with a significantly lower risk of type 2 diabetes. For every 1 km increase in speed, the risk drops by 9%. Regular brisk walking may be an effective strategy to stave off the disease.
The DAPPER study found that dapagliflozin 5mg daily reduced cardiovascular events, including cardiovascular death or hospitalization, in patients with chronic heart failure and type 2 diabetes. This was the first report to show this effect at a dose of 5mg.
Researchers found that using doctor- and patient-oriented materials improved conversations about erectile dysfunction (ED) among Asian men with diabetes. The study suggests that these materials can encourage treatment of ED, particularly in cultures where sex is viewed as taboo.
A new hydrogel drug delivery system has been developed that can transform daily injections of diabetes and weight control drugs into once every four months. The system has shown promising potential in laboratory tests and could improve management of Type 2 diabetes, patient drug compliance, and long-term health outcomes.
A simulation study suggests that a soft drink tax in Germany would reduce sugar consumption and illness rates, including type 2 diabetes, resulting in significant financial savings. The estimated economic benefits of introducing such a tax range from 9.5 billion to 16 billion euros over the next two decades.
A tiered tax system incentivizes companies to reduce sugar content, leading to a significant reduction in sugar intake and medical costs. The study predicts that such a tax could prevent over 244,000 cases of type 2 diabetes and save €16.0 billion.
SourcePLOS·JournalPLOS Medicine·TypeComputational simulation/modeling·DateNov 21, 2023
Research finds that poor nutrition contributes to both type 2 diabetes and mental health disorders like depression and anxiety. A balanced diet rich in fruits, vegetables, whole grains, lean protein, and low-fat dairy can reduce the risk of these conditions.
Social determinants like food insecurity and housing issues were linked to lower likelihoods of receiving diabetic retinopathy screening. The study highlights the importance of addressing barriers to care for promoting health equity.
A large Asian cohort study identified systolic blood pressure targets below 130 mmHg and diastolic targets between 80-89 mmHg as key to reducing cardiovascular mortality. The findings underscore the need for cautious blood pressure management in patients with diabetes.
Researchers analyzed FDA and patent records to find that manufacturers extended market exclusivity by filing additional patents after FDA approval and obtaining patents on delivery devices. This resulted in a median of 16 years of protection, surpassing other top-selling small-molecule drugs.
A new USC study identifies two metabolites that may predict which young Latino people are most likely to develop prediabetes. The research found that allylphenol sulfate and caprylic acid were the most predictive of prediabetes when combined with other risk factors.
Researchers are developing a bioengineered pancreas-like tissue using innovative biomaterials and engineered cells. The goal is to implant these cell-laden scaffolds into patients who need help managing their glucose levels.
A study of 54,000 participants found that diabetes was associated with an elevated risk of colorectal cancer. The association was attenuated for those who completed colonoscopies, highlighting the potential benefits of preventative screening.
A new study found that curtailing sleep by 90 minutes for six weeks increased insulin resistance in women, particularly postmenopausal women. Insulin resistance was also linked to an increased risk of developing type 2 diabetes.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
Researchers from Helmholtz Munich discovered that GIP decreases body weight by interacting with specific inhibitory neurons in the brain, offering a revolutionary approach to patients worldwide. The study reveals the underlying molecular mechanisms of GIPR:GLP-1R co-agonists and their potential as next-generation anti-obesity drugs.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a new mechanism for insulin regulation in type 2 diabetes. The preclinical discovery provides a new chemical tool for probing the biology of diabetes and could lead to better treatments.